Daridorexant Hydrochloride | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Daridorexant Hydrochloride
US Exclusivities

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Daridorexant Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 5 Listed Suppliers, $ API Reference Price

5 API Suppliers
5 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

1 Data Compilation #PharmaFlow

PATENTS & EXCLUSIVITIES

6 US Patents, 6 US Exclusivities

6 US Patents
6 US Exclusivities

$ API Ref.Price (USD/KG) : 49,323 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

6 All

01 6IDORSIA

filter Product Reset all filters

6 All

01 6DARIDOREXANT HYDROCHLORIDE

filter Exclusivity Expiration Date Reset all filters

6 All

01 22027-04-07

02 42027-09-30

filter Exclusivity Code Reset all filters

6 All

01 2M-200

02 2M-310

03 2NCE

Product Main Page

IDORSIA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DARIDOREXANT HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-310

Exclusivity Expiration Date

2027-09-30

Application Number

214985

Product Number

2

Exclusivity Details

01

IDORSIA

DARIDOREXANT HYDROCHLORIDE

Cancer Research

Not Confirmed

IDORSIA

Switzerland

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DARIDOREXANT HYDROCHLORIDE

Exclusivity Code : M-310

Exclusivity Expiration Date : 2027-09-30

Application Number : 214985

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

IDORSIA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DARIDOREXANT HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2027-04-07

Application Number

214985

Product Number

2

Exclusivity Details

02

IDORSIA

DARIDOREXANT HYDROCHLORIDE

Cancer Research

Not Confirmed

IDORSIA

Switzerland

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DARIDOREXANT HYDROCHLORIDE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2027-04-07

Application Number : 214985

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

IDORSIA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DARIDOREXANT HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-200

Exclusivity Expiration Date

2027-09-30

Application Number

214985

Product Number

2

Exclusivity Details

03

IDORSIA

DARIDOREXANT HYDROCHLORIDE

Cancer Research

Not Confirmed

IDORSIA

Switzerland

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DARIDOREXANT HYDROCHLORIDE

Exclusivity Code : M-200

Exclusivity Expiration Date : 2027-09-30

Application Number : 214985

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

IDORSIA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DARIDOREXANT HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-310

Exclusivity Expiration Date

2027-09-30

Application Number

214985

Product Number

1

Exclusivity Details

04

IDORSIA

DARIDOREXANT HYDROCHLORIDE

Cancer Research

Not Confirmed

IDORSIA

Switzerland

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DARIDOREXANT HYDROCHLORIDE

Exclusivity Code : M-310

Exclusivity Expiration Date : 2027-09-30

Application Number : 214985

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

IDORSIA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DARIDOREXANT HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2027-04-07

Application Number

214985

Product Number

1

Exclusivity Details

05

IDORSIA

DARIDOREXANT HYDROCHLORIDE

Cancer Research

Not Confirmed

IDORSIA

Switzerland

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DARIDOREXANT HYDROCHLORIDE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2027-04-07

Application Number : 214985

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

IDORSIA

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

DARIDOREXANT HYDROCHLORIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-200

Exclusivity Expiration Date

2027-09-30

Application Number

214985

Product Number

1

Exclusivity Details

06

IDORSIA

DARIDOREXANT HYDROCHLORIDE

Cancer Research

Not Confirmed

IDORSIA

Switzerland

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

DARIDOREXANT HYDROCHLORIDE

Exclusivity Code : M-200

Exclusivity Expiration Date : 2027-09-30

Application Number : 214985

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!